Naveris

About

The company is dedicated to improving outcomes for millions at risk of developing viral-induced cancers. Our mission focuses on delivering disruptive technology and novel molecular diagnostics.


Products or Services

NavDx-The first and only clinically validated circulating TTMV® DNA blood test that aids in the detection of HPV-driven cancer.

Contacts

Primary
Erik Duffy
Vice President of Market Access

ExhibitorIndustry Relations Council
Powered By GrowthZone